NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

NRx Pharmaceuticals' subsidiary, HOPE Therapeutics, has treated its first patients using Zeta Surgical's FDA-cleared Zeta TMS Navigation System at clinics in West Palm Beach and Sarasota, Florida. The deployment marks the transition from research to active patient care, utilizing AI-powered, sub-millimetric image guidance for the treatment of Major Depressive Disorder and other neurological conditions.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.